- Report
- October 2023
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- November 2023
- 73 Pages
Global
From €906EUR$995USD£776GBP
- Report
- October 2021
- 72 Pages
Global
From €1361EUR$1,495USD£1,166GBP
- Report
- September 2024
- 107 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2023
- 104 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2023
- 108 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2025
- 104 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- May 2023
- 93 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2022
- 173 Pages
Global
€5916EUR$6,500USD£5,071GBP
- Book
- February 2022
- 624 Pages
- Book
- July 2023
- 560 Pages
- Book
- April 2021
- 288 Pages
- Book
- July 2023
- 560 Pages

The Biosystems market is a subset of the biotechnology industry that focuses on the development and production of biological systems and components. This includes the production of biological materials, such as proteins, enzymes, and antibodies, as well as the development of systems for the delivery of these materials. Biosystems are used in a variety of applications, including drug discovery, diagnostics, and medical research.
The Biosystems market is driven by advances in biotechnology, such as the development of new technologies and techniques for the production of biological materials. Additionally, the increasing demand for personalized medicine and the development of new treatments for diseases are driving the growth of the Biosystems market.
Some of the major companies in the Biosystems market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Illumina, and Qiagen. These companies are involved in the development and production of biological materials, as well as the development of systems for the delivery of these materials. Show Less Read more